Sort   by:  
 Page size 
UnknownKinase inhibitor pulldown assay (KiP) for clinical proteomics.
Not available
S-EPMC10790396 | biostudies-literature
UnknownEstablishing selectivity of FAK-paxillin PPI inhibitor using pulldown proteomics and a focal adhesion protein selectivity panel.
Not available
S-EPMC12765108 | biostudies-literature
ProteomicsPulldown proteomics of XybR in SirexAA-E
Streptomyces sp. SirexAA-E chnages secretion of enzymes that can degrade xylan. These enzymes transcription is regulated by a transcriptional regulator. To determine the dominant regulator, we performed pulldown proteomics, using some promoter regions (P0265, P0357, P5230) which are related to xylan...
ORGANISM(S): Streptomyces sp. SirexAA-E 
2025-11-11 | PXD061680 | Pride
Pulldown proteomics Xylan Hemicellulose Transcriptonal regulator 
ProteomicsRNA pulldown-MS, Dlg4 RNA in mouse brain
Goal was to identify RNA-binding proteins with a preference for m6A-modified RNA using an RNA bait generated from a known m6A site in the Dlg4 (PSD-95) mRNA 3`-UTR. By comparison of differential enrichment between m6A-RNA pulldown fractions and A-RNA or no RNA fractions, we can identify m6A-binding ...
ORGANISM(S): Mus musculus (Mouse) 
2022-10-13 | PXD034159 | Pride
Pulldown M6a Rna Lc-ms/ms 
ProteomicsRNA pulldown-MS, Dlg4 RNA in mHippoE-2 cells
Goal was to identify RNA-binding proteins with a preference for m6A-modified RNA using an RNA bait generated from a known m6A site in the Dlg4 (PSD-95) mRNA 3`-UTR. By comparison of differential enrichment between m6A-RNA pulldown fractions and A-RNA or no RNA fractions, we can identify m6A-binding ...
ORGANISM(S): Mus musculus (Mouse) 
2022-10-13 | PXD034161 | Pride
Pulldown M6a Rna Lc-ms/ms 
ProteomicsKinase Inhibitor Pulldown Assay (KiP) for Clinical Proteomics
Protein kinases are frequently dysregulated and/or mutated in cancer and represent essential targets for therapy. Accurate quantification is essential, but current approaches are inadequate. For breast cancer treatment for example, the identification and quantification of the protein kinase ERBB2 is...
ORGANISM(S): Homo sapiens (Human) 
2024-01-26 | PXD044655 | Pride
Human Breast Cancer Kinase 
ProteomicsKinase Inhibitor Pulldown Assay (KiP) for Clinical Proteomics (SureQuant)
Protein kinases are frequently dysregulated and/or mutated in cancer and represent essential targets for therapy. Accurate quantification is essential, but current approaches are inadequate. For breast cancer treatment for example, the identification and quantification of the protein kinase ERBB2 is...
ORGANISM(S): Homo sapiens (Human) 
2024-01-26 | PXD046169 | Pride
Breast cancer Is-prm Surequant Kip 
ProteomicsPulldown GST-SH3 domains of Endophilin and rat brain lysates
Pulldown experiments using GST-SH3 domains from hman Endophilin A1, A2 and A3 and rat brain lysates
ORGANISM(S): Rattus norvegicus (Rat) 
2018-08-06 | PXD010090 | Pride
Pulldown Endophilin Rat brain lysates 
UnknownChemical pulldown combined with mass spectrometry to identify the molecular targets of antimalarials in cell-free lysates.
Not available
S-EPMC9841287 | biostudies-literature
ProteomicsProbing the Role of O-GlcNAcylation in Modulating Protein-DNA Interactions: Insights from a Proteomic Transcription Factor Response Element-Based Pulldown Screening Approach
O-linked β-N-acetylglucosamine (O-GlcNAc), a critical post-translational modification (PTM) predominantly found in the nucleus, plays a substantial role in regulating gene expression by modulating transcription factors (TFs) activity. Herein, by utilizing a pulldown screening approach termed as tand...
ORGANISM(S): Homo Sapiens 
PXD057128 |
Sort   by:  
 Page size